Iscartrelvir is an
investigational new drug
The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical industry, pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug inte ...
developed by the
Westlake University
Westlake University ( zh, 西湖大学, labels=no) is a private university in Hangzhou, Zhejiang, China. It was founded in October 2018.
Westlake University ranked 84th in the world for Nature Index 2021 Young Universities (Leading 150 Young U ...
for the treatment of
COVID-19
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.
The symptoms of COVID‑19 can vary but often include fever ...
. It targets the SARS-CoV-2
3CL protease, which is crucial for the replication of the virus responsible for COVID-19.
See also
*
3CLpro-1
*
Rupintrivir
Rupintrivir (AG-7088, Rupinavir) is a peptidomimetic antiviral drug which acts as a 3C and 3CL protease inhibitor. It was developed for the treatment of rhinoviruses, and has subsequently been investigated for the treatment of other viral dise ...
References
Secondary amines
Anilines
Benzamides
Bromobenzene derivatives
Nitrobenzenes
Cyclohexanes
Isoquinolines
{{antiinfective-drug-stub